We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDAQ
1501
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
$2.91M 0.01%
290,130
– –
FISV
1502
PUT
Fiserv Inc
FISV
$29B
$2.9M 0.01%
28,700
+22,900
+395% +$2.28M
OCEA
1503
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$2.89M 0.01%
277,624
– –
AIIOW
1504
CALL
Robo.ai Inc Warrant
AIIOW
$594K
$2.89M 0.01%
+269,000
New +$80.7K
ASRT
1505
DELISTED
Assertio
ASRT
$2.87M 0.01%
44,569
-13,723
-24% -$603K
DNMR
1506
DELISTED
Danimer Scientific, Inc.
DNMR
$2.83M 0.01%
39,594
+3,960
+11% +$375K
IHI icon
1507
iShares US Medical Devices ETF
IHI
$3.15B
$2.83M 0.01%
+53,900
New +$2.74M
ADPT icon
1508
Adaptive Biotechnologies
ADPT
$3.63B
$2.83M 0.01%
370,471
-61,999
-14% -$482K
LGACW
1509
CALL
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$2.83M 0.01%
279,830
– –
MAA icon
1510
Mid-America Apartment Communities
MAA
$15.8B
$2.83M 0.01%
18,016
-195,408
-92% -$30.4M
ACQRW
1511
CALL
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$2.83M 0.01%
279,997
– –
OCAXW
1512
CALL
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$2.82M 0.01%
274,997
– –
EIDO icon
1513
iShares MSCI Indonesia ETF
EIDO
$469M
$2.82M 0.01%
+125,908
New +$2.92M
CABO icon
1514
Cable One
CABO
$248M
$2.81M 0.01%
+3,950
New +$2.94M
SMCI icon
1515
Super Micro Computer
SMCI
$18.4B
$2.8M 0.01%
+341,240
New +$2.6M
ARBGW
1516
CALL
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$2.79M 0.01%
276,661
– –
LH icon
1517
Labcorp
LH
$25.5B
$2.79M 0.01%
13,795
+9,074
+192% +$1.77M
MCHB
1518
Mechanics Bancorp
MCHB
$3.51B
$2.79M 0.01%
101,095
-8,511
-8% -$233K
DLX icon
1519
Deluxe
DLX
$1.27B
$2.78M 0.01%
163,975
-84,493
-34% -$1.5M
CBRGW
1520
CALL
DELISTED
Chain Bridge I Warrants
CBRGW
$2.78M 0.01%
270,399
– –
BRSL
1521
Brightstar Lottery PLC
BRSL
$1.94B
$2.78M 0.01%
+122,526
New +$2.66M
PCAR icon
1522
PACCAR
PCAR
$69.4B
$2.77M 0.01%
+41,958
New +$2.74M
PLYA
1523
DELISTED
Playa Hotels & Resorts
PLYA
$2.75M 0.01%
421,319
-1,250,852
-75% -$7.42M
EMBJ
1524
Embraer S.A. ADS
EMBJ
$12.2B
$2.75M 0.01%
251,562
-1,820,402
-88% -$18.5M
ABBV icon
1525
AbbVie
ABBV
$467B
$2.75M 0.01%
16,999
-29,179
-63% -$4.47M
59 60
61
62 63

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.